| abstract |
The present disclosure focuses on specific naturally occurring mutant maize CAD2 genes, which altered genes contribute to the bml maize phenotype in specific maize lines. In some embodiments, compositions and methods utilizing nucleic acid molecules comprising a mutant CAD2 gene and/or markers linked to the mutant CAD2 gene are provided. |